CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-06 | Eisner Mark EVP, Chief Medical Officer | Shares withheld for taxes | −1,860 | $0.96 | $2K | 159,917 |
| 2023-09-01 | Eisner Mark EVP, Chief Medical Officer | Shares withheld for taxes | −1,085 | $1.06 | $1K | 161,777 |
| 2023-06-07 | Eisner Mark EVP, Chief Medical Officer | Sale | −2,042 | $17.04 | $35K | 162,862 |
| 2023-06-02 | Eisner Mark EVP, Chief Medical Officer | Sale | −1,090 | $18.83 | $21K | 164,904 |
| 2023-04-04 | Eisner Mark Chief Medical Officer | Sale | −9,182 | $18.78 | $172K | 165,994 |
| 2023-03-10 | Eisner Mark Chief Medical Officer | Sale | −3,885 | $20.20 | $78K | 181,431 |
| 2023-03-10 | Eisner Mark Chief Medical Officer | Sale | −6,255 | $20.20 | $126K | 175,176 |
| 2023-03-08 | Eisner Mark Chief Medical Officer | Sale | −7,363 | $21.16 | $156K | 165,133 |
| 2023-03-08 | Eisner Mark Chief Medical Officer | Grant or award | +7,732 | 172,865 | ||
| 2023-03-08 | Eisner Mark Chief Medical Officer | Grant or award | +12,451 | 185,316 | ||
| 2023-03-02 | Eisner Mark Chief Medical Officer | Sale | −1,187 | $21.87 | $26K | 172,496 |
| 2023-02-21 | Eisner Mark Chief Medical Officer | Grant or award | +32,500 | 173,683 | ||
| 2023-02-21 | Eisner Mark Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2022-12-01 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −1,084 | $15.04 | $16K | 141,183 |
| 2022-09-30 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −6,777 | $13.01 | $88K | 142,267 |
| 2022-09-01 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −756 | $13.09 | $10K | 149,044 |
| 2022-06-01 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −1,141 | $9.61 | $11K | 149,800 |
| 2022-03-31 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −6,442 | $12.02 | $77K | 150,941 |
| 2022-03-01 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −756 | $13.62 | $10K | 157,383 |
| 2022-02-14 | Eisner Mark Chief Medical Officer | Grant or award | +60,000 | 158,139 |
Page 1 of 2 · 25 trades